Loading..
Translate
Text Highlighter

Bookmark

PDF

Share

Report a problem
AMICUS AI
Citation Codes
Equivalent Citations
citation codes
Case Number
Disposition
Attorney(S)
Judges
Acts
  • INCOME TAX ACT 1961
  • SECTION 263 INCOME TAX ACT 1961
  • Rule 6(7A) of the I.T. Rules
  • Rule 6(7A) of the Income Tax Rules, 1962
  • Income tax Act or the Income Tax Rules
  • Act of Rs.237,77,05,310/-,
  • u/s 263 of the Income-tax Act, 1961
  • sub-section 2(AB) of section (1AB)
  • Act read with Rule 6 of the Income Tax Rules.
  • provision of section 35(2AB) read with Rule 06 of I.T. Act
  • Rule_6(7A) of I.T. Rules. The provision of section 35(2AB)
Are you a practicing lawyer?
Enhance your digital presence and reach by creating a Casemine profile.
Upload pleading to use the new AI search
Cites
Cited by
Citation Codes
Equivalent Citations
citation codes
Case Number
Disposition
Attorney(S)
Judges
Acts
  • INCOME TAX ACT 1961
  • SECTION 263 INCOME TAX ACT 1961
  • Rule 6(7A) of the I.T. Rules
  • Rule 6(7A) of the Income Tax Rules, 1962
  • Income tax Act or the Income Tax Rules
  • Act of Rs.237,77,05,310/-,
  • u/s 263 of the Income-tax Act, 1961
  • sub-section 2(AB) of section (1AB)
  • Act read with Rule 6 of the Income Tax Rules.
  • provision of section 35(2AB) read with Rule 06 of I.T. Act
  • Rule_6(7A) of I.T. Rules. The provision of section 35(2AB)
Smart Summary

Tribunal Opinion Summary — ITA No. 1390/Ahd/2016 (AY 2009-10)

Factual and Procedural Background

This appeal arises from an order dated 28.03.2016 of the Principal Commissioner of Income Tax (PCIT), Central Circle-2, Vadodara, exercising revisional jurisdiction under section 263 of the Income Tax Act, 1961 in respect of a regular assessment framed by the Assessing Officer on 30.01.2014.

The assessee is Sun Pharmaceutical Industries Ltd. (erstwhile Ranbaxy Laboratories Ltd.), a company engaged in manufacture and trading of pharmaceuticals and bulk drugs. The assessee filed its return on 27.09.2009 reporting a loss and was subject to scrutiny. In the return and supporting notes the assessee claimed weighted deductions under section 35(2AB) of the Act in relation to in-house Research & Development (R&D) expenditure: revenue R&D expenditure for weighted deduction of Rs. 2,03,86,37,456 and capital R&D expenditure for weighted deduction of Rs. 33,90,67,854, aggregating to Rs. 2,37,77,05,310.

The Department of Scientific & Industrial Research (DSIR) had issued an "Order of approval of in house Research & Development Facility" in Form 3CM dated 11.06.2009 listing the assessee's approved facilities. The Assessing Officer (AO) accepted the assessee's claim and allowed the weighted deduction when passing the assessment order under section 143(3) on 30.01.2014.

The PCIT issued a show cause notice dated 10.03.2016 proposing revision under section 263 on the ground that the AO allowed the weighted deduction without production of Form 3CL (the report/communication from the prescribed authority to the Director General (Income-tax Exemptions) regarding approval of expenditure), and therefore the AO's assessment was allegedly erroneous and prejudicial to the revenue. The assessee replied on 21.03.2016, relying on material on record (including Form 3CM) and judicial authorities. The PCIT proceeded to revise the assessment. The assessee appealed to the Income Tax Appellate Tribunal (Ahmedabad "B" Bench).

Legal Issues Presented

  1. Whether the Principal Commissioner of Income Tax was justified in invoking section 263 to revise the assessment on the basis that the AO allowed weighted deduction under section 35(2AB) without production of Form 3CL (approval/communication of expenditure by DSIR).
  2. Whether a claim for weighted deduction under section 35(2AB) for capital and revenue R&D expenditure (total Rs. 2,37,77,05,310) can be allowed in the absence of Form 3CL, when the assessee has Form 3CM approval of the in-house facility for the relevant period and has placed particulars before the AO.
  3. Whether the conditions for exercise of revisional jurisdiction under section 263 (that the assessment is erroneous and prejudicial to the revenue) were established on the facts of this case.

Arguments of the Parties

Appellant's (Assessee's) Arguments

  • The assessment sought to be revised was neither erroneous nor prejudicial to the revenue; reliance was placed on the apex court decision in Malabar Industrial Co. vs. CIT (243 ITR 83 (SC)) regarding the twin conditions for exercise of section 263 jurisdiction.
  • The assessee had placed on record notes to the return, computation and tax audit report (clause 15), and had filed documents during scrutiny demonstrating that it carried out in-house R&D for claiming weighted deduction under section 35(2AB).
  • The assessee had obtained Form 3CM approval of its in-house R&D facility (Order of approval) dated 11.06.2009; it contended it had fulfilled the conditions of section 35(2AB) read with Rule 6 and that Form 3CL is not a pre-condition that the assessee must produce before the AO to claim deduction.
  • The assessee relied on a number of judicial precedents (a catena of case law) to support its position that the AO was justified in allowing the deduction based on the material before him.

Respondent's (Revenue's / PCIT's) Arguments

  • The AO erroneously allowed weighted deduction under section 35(2AB) without the prescribed authority (DSIR) having approved the expenditure by issuing Form 3CL; therefore the AO failed to apply his mind and the assessment is erroneous and prejudicial to the revenue.
  • Rule 6(7A) of the Income Tax Rules contemplates that the prescribed authority shall submit its report in Form No. 3CL to the Director General (Income-tax Exemptions) within 60 days of granting approval; approval of expenditure by DSIR in Form 3CL is a pre-condition for allowing deduction in terms of section 35(2AB) and Rule 6.
  • Accordingly, PCIT invoked the Malabar test (two conditions) and held that the AO failed to make necessary inquiries and disallow the excess weighted deduction of Rs. 2,37,77,05,310, making the order erroneous and prejudicial to revenue.
  • The Departmental Representative also referred to several judicial decisions to support the revision under section 263 (as listed in the record), arguing those authorities supported the PCIT’s view or the need to scrutinize the AO’s allowance of the deduction.

Table of Precedents Cited

Precedent Rule or Principle Cited For Application by the Court
Malabar Industrial Co. vs. CIT, 243 ITR 83 (SC) Defines twin conditions for exercise of revisional jurisdiction under section 263 (that an assessment is erroneous and prejudicial to the revenue). PCIT relied on this decision to contend the AO's order met the twin conditions. The Tribunal considered the test but found, on the facts, that the assessee's claim was allowable and therefore the Malabar test was not satisfied to sustain revision.
ACIT vs. M/s. Torrent Pharmaceuticals (ITA No.3569/Ahd/2004) (Tribunal, decision dated 13.11.2009) Holds that weighted deduction is not to be restricted to the amount of necessary expenditure stated in Form 3CL. The Tribunal relied on this coordinate-bench decision to support the proposition that the amount in Form 3CL does not limit the allowable deduction and used it in reasoning in favour of the assessee.
CIT vs. CLARIS LIFESCIENCES Ltd., (2010) 326 ITR 251 (Gujarat) Holds that expenses incurred before Form 3CM approval cannot be denied for the purpose of section 35(2AB). The Tribunal treated this High Court decision as binding on the jurisdiction and followed its reasoning, stating it settles the proposition in favour of the assessee and distinguishing Revenue's contrary authorities.
Addl. CIT vs. Mukur Corporation, [1978] 111 ITR 312 (Guj.) Defines scope of the Commissioner (Appeals)/CIT's revisional jurisdiction under section 263. The Tribunal acknowledged this decision as explaining the scope of section 263 jurisdiction; however, on the facts it found the AO's acceptance of the claim was correct and thus Mukur did not assist the PCIT to overturn the assessment.
EIMCO K.C.P. Ltd. vs. CIT, [2000] 242 ITR 659 (SC) Discusses the ambit of section 263 jurisdiction in cases involving pendency of appeal before the CIT(A) (as cited by the parties). The Tribunal observed this precedent but found it not relevant to the facts before it for deciding whether the PCIT was right in revising the assessment.
Tejas Networks Ltd. vs. DCIT, [2015] 60 taxmann.com 309 (Karnataka) Involves section 35 deduction claims in light of section 43 (issues concerning definition of scientific research). The Tribunal noted the Revenue relied on this decision, but distinguished it as not binding in view of the jurisdictional High Court decision in CLARIS which the Tribunal followed.
Electronics Corporation Of India Ltd. vs. ACIT, [2012] 28 taxmann.com 280 (Hyd.) (Tribunal decision cited by Revenue on issues relating to R&D deductions and procedures) The Tribunal observed this Hyderabad-bench decision but distinguished it on facts and noted the binding effect of the jurisdictional High Court authority (CLARIS).
DCIT vs. Mastek Ltd., [2012] 25 taxmann.com 133 (Guj.) Relates to Section 35 deduction claims vis-à-vis Section 43(4) (definition of scientific research). The Tribunal found this authority not germane to the core issue before it and therefore did not follow Revenue's reliance on it.

Court's Reasoning and Analysis

The Tribunal examined the documentary record and the legal framework set out in section 35(2AB) read with Rule 6 (and specifically Rule 6(7A)) of the Income Tax Rules, 1962. The Tribunal noted:

  • The prescribed authority for approval of in-house R&D facilities is the DSIR. The assessee had an Order of approval of in-house R&D facility in Form 3CM dated 11.06.2009, which listed the facilities and pertained to the previous year relevant to the impugned assessment year.
  • Rule 6(7A)(b) requires the prescribed authority to submit its report in Form No. 3CL to the Director General (Income-tax Exemptions) within 60 days of granting approval; the Tribunal characterized Form 3CL as a communication/intimation sent by the prescribed authority to the Department and observed that the assessee has no role in that specific correspondence.
  • Relying on a coordinate-bench tribunal decision in ACIT vs. Torrent Pharmaceuticals, the Tribunal observed that weighted deduction should not be restricted to the amount of expenditure mentioned in Form 3CL.
  • The Tribunal further relied on the jurisdictional High Court decision in CIT vs. CLARIS LIFESCIENCES Ltd. which held that expenses incurred before Form 3CM approval cannot be denied for section 35(2AB) purposes. The Tribunal regarded this High Court decision as binding for its jurisdiction and followed it.
  • Applying these authorities and the factual record (presence of Form 3CM approval and particulars placed before the AO during scrutiny), the Tribunal concluded that the assessee was entitled to the weighted deduction for the capital and revenue R&D expenses amounting to Rs. 2,37,77,05,310 and that the AO had rightly allowed the deduction after verifying the particulars.
  • The Tribunal considered and distinguished the precedents and arguments relied upon by the Revenue (including authorities addressing the scope of section 263 or issues under section 43), concluding that those authorities did not persuade it to displace the position established by CLARIS and the Torrent decision in respect of the facts before it.

Holding and Implications

Holding: APPEAL ALLOWED.

Implications (direct effect on the parties):

  • The Tribunal allowed the assessee's appeal and declined Revenue's revision under section 263; the PCIT's exercise of revisional jurisdiction was not sustained on these facts.
  • The Tribunal held that the assessee was entitled to claim the weighted deduction under section 35(2AB) for the capital and revenue R&D expenses totaling Rs. 2,37,77,05,310, given the Form 3CM approval of the in-house facility and the authorities it followed.
  • The Tribunal did not purport to lay down a new legal principle; it applied and followed existing tribunal and High Court authority (notably Torrent and CLARIS) in resolving the matter in favour of the assessee. No broader precedent beyond the application of those authorities was announced by the Tribunal in this order.

Source: Order of the Income Tax Appellate Tribunal, Ahmedabad "B" Bench (Judicial Member: S. S. Godara; Accountant Member: N. K. Billaiya), dated 22.12.2016 — ITA No. 1390/Ahd/2016 (Assessment Year 2009-10).

    Sun Pharmaceutical Industries Ltd. v. Cit

    IN THE INCOME TAX APPELLATE TRIBUNAL

    AHMEDABAD "B" BENCH AHMEDABAD

    BEFORE SHRI N. K. BILLAIYA, ACCOUNTANT MEMBER,

    AND SHRI S. S. GODARA, JUDICIAL MEMBER.

    ITA No. 1390/Ahd/2016 (Assessment Year: 2009-10)

    Sun Pharmaceutical Industries Ltd. (Erstwhile Ranbaxy Laboratories Ltd.) SPARC, Tandalja, Baroda - 390020 Appellant Vs.

    Pr. Commissioner of Income Tax, Central Circle-2, 2ndFloor, Aaykar Bhavan, Race Course Circle, Baroda - 390007 Respondent

    PAN: AADCS3124K

    आवेदक क ओर से / By Assessee : Shri S. N. Soparkar, Shri P. M. Mehta & Shri Parin Shah, A.Rs.

    राज व क ओर से / By Revenue : Shri R. N. Parbat, CIT. D.R. सनुवाई क तारख/Date of Hearing : 14.10.2016 घोषणा क तारख/Date of

    Pronouncement : 22 .12.2016

    ORDER

    PER S. S. GODARA, JUDICIAL MEMBER

    This assessee's appeal for assessment year 2009-10 arises against the Principal CIT-2, Vadodara's order dated 28.03.2016, in case no. Pr.CIT-

    1

    2/263/4/2015-16, in proceedings under section 263 of the Income Tax Act, 1961; in short "the Act".

    2. We come to assessee's pleadings first. It challenges the PCIT's order in question revising a regular assessment framed on 30.01.2014 by the Assessing Officer on the ground that he had wrongly accepted its claim of weighted deduction u/s.35(2AB) of the Act involving revenue and capital expenses of Rs.2,03,86,37,456/- and Rs.33,90,67,854/-; respectively aggregating to Rs.237,77,05,310/-. Learned PCIT further directs the Assessing Officer to frame afresh assessment in assessee's case. All this culminates into assessee's grievance as adjudicated in the instant appeal hereunder.

    3. We advert to the relevant facts now. The assessee (earlier M/s. Ranbaxy Laboratories Ltd.) is a company manufacturing and trading in pharmaceuticals and bulk drugs. It filed its return on 27.09.2009 stating loss of Rs.44,14,10,77,665/- along with book loss computed u/s.115JB amounting to Rs.29,47,15,15,100/-. The Assessing Officer took up scrutiny. He issued Section 143(2) notice on 23.08.2010 inter alia seeking details of assessee's weighted deduction claim raised hereinabove alongwith necessary approval thereof. The assessee filed reply on 10.09.2010 placing on record the above particulars sought for. It is evident to us that assessee's return filed also contained its notes of accounts statement indicating the factual backdrop of its weighted deduction claim. It transpires that assessee's in house research and development facilities were approved by the prescribed authority on 11.06.2009 qua the impugned expenses incurred during the financial year 2008-09. The Assessing Officer then framed a regular assessment on 30.01.2014 accepting assessee's above weighted deduction claim.

    2

    4. This case file indicates that the learned PCIT thereafter sought to revise the above regular assessment by exercising Section 263 revisional jurisdiction. He issued a show cause notice dated 10.03.2016 for the following reasons:

    "2. If was noticed from the records that the assesses had claimed deduction u/s. 35(2AB) of the Act on account of R & D revenue and capital expenditure @ 100% and 150% respectively in the return of Income, without the approval of the prescribed authority i.e. DSIR In Form 3CL, as under :

    Particulars Weighted deduction claimed by the assessee
    Deduction claimed of R & D Revenue expenditure @ 150% Rs. 2,03 ,86,37,456/-
    Deduction claimed of R & D capital @ 150% Rs. 33,90,67,854/-
    Total weighted deduction claimed Rs. 237,77,05,310/-

    The A.O. white finalising assessment u/s. 143(3) of the Act allowed the weighted

    deduction u/s.35(2AB) of the Act of Rs.237,77,05,310/-, claimed by the assessee

    (without the approval of the prescribed authority i.e. D.S.I.R. in Form 3CL, though

    the assessee was not entitled to claim the said deduction in accordance with

    the provision of section 35(2AB) read with Rule 06 of I.T. Act

    The Assessing Officer, erred in not appreciating the facts in proper perspective

    and did not made disallowance of Rs.237,77,05,310/- to the total income of the

    assessee., while finalizing assessment u/s. 143(3) of the Act, though the assessee by

    claiming deduction u/s. 35(2AB) of the Act without fulfilling conditions laid down

    for claiming deduction, had reduced its taxable income and consequently reduced

    its tax liability.

    3. In view of the above mentioned facts, it is clearly established that the A.O. did not properly examine and had not applied his mind for making addition on the issue of excess claim of weighted deduction u/s. 35(2AB) of the Act, while passing order u/s. 143(3) r.w.s. 144(C) of the Act., Therefore, the order dated 30-01-2014 u/s. 143(3) r.w.s. 144(C) of the Act passed by the Addl. C.I.T. Range-15, New Delhi has been found to be erroneous in so far as it is prejudicial to the interest of the revenue. In view of discussion mentioned in above para, it is proposed to take suitable action u/s 263 of the Income-tax Act, 1961 in respect of aforesaid order,

    4. In the above circumstances, the assessment order passed by the Assessing Officer is considered to be erroneous as well as prejudicial to the interest of revenue. You are, therefore, allowed an opportunity of being heard and show cause as to why an order enhancing or modifying the assessment or cancelling the assessment and directing a fresh assessment within the meaning of section 263 of the I. T. Act may not be passed in the case of Assessee Company."

    3

    5. The assessee filed reply to the above show cause notice on 21.03.2016. It first of all raised a legal contention that the above assessment sought to be revised was neither erroneous nor prejudicial to interest of the Revenue as per hon'ble apex court's land mark decision in Malabar Industrial Co. vs. CIT

    243 ITR 83 (SC). It then pleaded to have placed all necessary documents of having carried out in house research and development for the purpose of claiming the above weighted deduction u/s.35(2AB) of the Act since having filed notes to return of income, computation of income along with clause 15 of tax audit report as followed by its reply to the scrutiny notice hereinabove. The assessee would highlight the fact of having obtained Form 3CM approval from the prescribed authority. The assessee's case thereafter was that it fulfilled each and every condition for claiming the impugned weighted deduction as prescribed u/s.35(2AB) of the Act read with Rule 6 of the Income Tax Rules. It further quoted a catena of case law to buttress all its submissions. We find that all this failed to impress learned Principal Commissioner of Income Tax. He declines assessee's various pleas in the order under challenge extracted as follows:

    "5. I have considered the facts of the case and the submission of the assessee. The contention of the assessee is not acceptable It is an undisputed legal position that where the A.O, has not computed the correct total income or allowable claim or deduction and where no proper enquiries, investigations or examination of the materials has been carried out, such assessment order is erroneous in so far as prejudicial to the interest of the revenue and that calls for action u/s. 263 of the Act If the A.O had done so, the computation of income or allowance would have been in conformity of facts as well as in !aw. It is noticed that the assessee has claimed deduction u/s, 35(2AB) on account of R & D Revenue and capita! expenditure @ 50% & 150% respectively. The assessee has wrongly claimed and was allowed weighted deduction for R & D expenditure by the A.O,, though the assessee did not submit report of the prescribed authority i.e. D.S.I.R. In form 3CL. This shows that the AO has failed to take notice of the claim of the assessee and erroneously allowed the wrong claim made by the assesseee, which means that the order so passed is erroneous within the meaning of section 263 of the Act. Further excess weighted deduction allowed was not in accordance with law as laid down by Act and judicial pronucement, Theerfore the order passed by the AO Is prejudcial to the

    4

    inerrest of revenue. Thus the twin condition as laid down in the decision of Malabar Industrial case ( supra) are satisfied in this case. Hence, the order sought to be revised is erroneous as well prejudicial to the interest of revenue. Hence , the contention of the assessee is not tenable in law.

    6. With regards to the submissions on merit on weighted deduction claimed by the assessee u/s. 35(2AB) , It was submitted by the assessee that it was not a deviation from the law, out was in accordance with the provision of section 35(21AB) r.w.s. r. 6 of the Income tax Rules. Relying on the provisions of section 35(2AB) of the Act and various judicial decisions, the assessee contended that the A.O after verifying the annual accounts, return of income and tax audit report, the Assessing Officer had decided to accept the contention of the assessee. It was the assesseessee's view that there is no requirement under the Income tax Act or the Income Tax Rules for either the assessee to produce Form 3CL and the A.O. to allow deduction only on the production of Form 3CL. The asssessee also contented that the issuance of Form 3CL was not the obligation of the assessee and it cannot be denied of benefits which it was 3CL was not the obligation of the assessee and it cannot be denied of benefits which it was otherwise entitled to because of non issuance of Form 3CL which was the responsibility of the DSIR. It was the assessee's contention that the Assessing Officer after considering all the relevant factual details and after considering the judicial precedents on the subject had decided to allow deduction u/s. 35(2AB) even where the assessee had not received Form 3CL, The assessee further contended that it had fulfilled all the conditions for claiming deduction u/s. 35(2AB) of the Act. The assessee company vide its above referred letter dated 21-03-2016, has filed Form No. 3CH (Order of approval of in house Research and Development Facility) issued by Secretary, D.S.R.I.R, New Delhi on 11-06-2009.

    6.1 I have considered the facts of the case on merit and of the view that the contention of the assessee is not acceptable . On a plain reading of section 35(2AB), of the Act, it is crystal clear that expenditure on scientific research or in house research facility as approved by the prescribed authority i.e.. D.S.I.R shall be allowed as deduction. Further Rule 6(7A) of the I.T. Rules read as under :

    "Rule 6(7A) Approval of expenditure incurred on in house research and development facility by a company under sub-section 2(AB) of section (1AB) shall be subject to the following conditions namely :

    (a) The facility should not relate purely to market research, sales promotion quality control, testing, commercial production, style changes, routing data collection or activities of a like nature

    (b) The prescribed authority shall submit its report in relation to the approval of in house Research and Development facility in Form No. 3CL to the Director General (Income tax Exemption) within 60 days of its granting approval

    5

    (c) The company shall maintain a separate account for each approved facility, shall be audited annually and a copy thereof shall be furnished to the Secretary, Department of Scientific and Industrial Research by 31st day of October of each succeeding year

    (d) Assets acquired in respect of development of scientific research and development facility shall not be disposed of without the approval of the Secretary, Department of Scientific and Industrial Research

    6.2. The assessee Company, vide its above referred letter dated 21-03- 2016 has submitted copy of Order of approval of tn-house Research and Development facility in Form 3CM, but has not filed Form No. 3CL i.e. approval of expenditure issued by the Secretary, D.S.I.R.

    6.3 From the above it is clear that approval of expenditure on in house research and development facility by D.S.I.R, is a pre condition for claiming deduction u/s. 35(2AB) of the Act,. It thus implies deduction u/s. 35(2AB) of the Act is determined and allowable to the extent of expenditure on scientific research or on in house research and development facility approved by D.S.I.R. Had it not been so, when words "expenditure incurred" would not have find place in the contents of Rule_6(7A) of I.T. Rules. The provision of section 35(2AB) mandates that approval of D.S.I.R., is the appropriate authority vested with the powers to determine the extent to which approval of expenditure can be accorded to an assessee who has incurred expenditure on R & D Facility, after considering ail the issues involved., after pursuing the report of the assessee in the matter. The intention of the legislature in introducing the concept of approval of expenditure on R & D in section 35(2AB) r.w.r 6 of the Act is to enable the assessee to achieve the objective of enjoying fruits of R & D facility for furtherance of its business activity and at the same time to ensure that the assessee is not allowed to claim excess weighted deduction u/s, 35(2AB) of the Act. Thus the approval of expenditure accorded by D.S.I.R. in form 3CL is a guiding factor to the A.O. to determine as to whether the assessee had correctly claimed weighted deduction u/s. 35(2AB) of the Act or not. In the instant case, the assessee has not produced any evidence to prove that it had filed all requisite documents and submitted report for purpose of certification of claim of R & D expenditure by its Statutory Auditor to the D.S.I.R. to enable the D.S.I.R. to issue order of approval of said expenditure in Form 3CL. The assessee company cannot be allowed to claim weighted deduction u/s. 356(2AB) of the Act, without production of approval of expenditure on R & D in form No. 3CL.

    6.4. The assessee has claimed weighted deduction for R & D expenditure of capital expenditure mentioned hereunder Deduction claimed of R & D Rs. 2,03,86,37,456/- Expenditure @ 50% of Revenue debited in P & L A/c.

    Revenue expenditure

    6

    Deduction claimed of R & D Capital expenditure 150% R s. 33,90,67,854/-
    Total, weighted deduction claimed Rs. 2,37,77,05,310/-

    6.5. The A.O. had simply accepted the assessee's contention on claim of weighted deducted u7s. 35(2AB) of the Act pertaining to R & D capital expenditure as well as revenue expenditure on face value without going into merits of assessee's submission in this regard. The above facts reveal that the A.O. by not making disallowance of weighted deduction u/s. 35(2AB) of the Act to the tune of Rs. 2,37,77,05,3107- in his order u/s. 1433(3) r.w.s. 144C of the Act, failed to analyse the facts correctly in proper perspective. Therefore, the order of the A.O. is erroneous in so far as prejudicial to the interest of the revenue

    6. We have heard both the parties. Case file perused. There does not appear to be any dispute that the assessee is admittedly an entity running the specified in house research and development facilities. The prescribed authority in the instant case is the "DSIR" i.e. Department of Scientific & Industrial Research, Ministry of Science & Technology, Government of India. This prescribed authority has undisputedly issued "Order of approval of in house Research & Development Facility u/s.35(2AB) of the Income Tax Act, 1961" in Form 3CM on 11.06.2009 as pertaining to the previous year relevant to the impugned assessment year. It further contains a list of assessee's various in house research & development facilities. Ld. PCIT's case as made out in his above extracted findings is that the assessee has failed to produce Form 3CL with respect to approval of its impugned revenue and capital expenses. His view is that the Assessing Officer ought not to have accepted assessee's weighted deduction in absence of the above approval Form 3CL.

    7. We have given our thoughtful consideration to rival contentions as well as ld. PCIT's concern expressed in order revising the above regular assessment. We deem its appropriate at this stage to throw some light on the nature and ambit of Form 3CL. The same comes under Rule 6(7A) of the Income Tax Rules, 1962 framed under the provisions of the Act. The above

    7

    sub rule is relevant for approval of expenditure incurred on in house research & development facility by a company u/s.35(2AB). Sub clause (b) thereof is the specific provision thereto stipulating that the prescribed authority shall submit its report in relation to the approval of in house Research & Development facility in Form No.3CL to the Director General (Income Tax Exemptions) within 60 days of its granting approval. The same is merely in the form of intimation to be sent from prescribed authority's end to the department. An assessee engaged in such Research & Development activity having already obtained Form 3CM approval of its facility has no role to play in such correspondence. We notice that a co-ordinate bench of this tribunal in ACIT vs. M/s. Torrent Pharmaceuticals ITA No.3569/Ahd/2004 decided on 13.11.2009 holds that the impugned weighted deduction is not to be restricted to the extent of the amount of the necessary expenditure incurred stated in such Form 3CL. We further find that hon'ble jurisdictional high court's decision in CIT vs. CLARIS LIFESCIENCES Ltd. (2010) 326 ITR 251 (Gujarat) upholds this tribunal's decision in the very assessee's case observing that expenses incurred before Form 3CM approval cannot be denied for the purpose of Section 35(2AB) weighted deduction. We follow the very reasoning to opine that facts of the instant case rather go a step further wherein the appellant has only claimed those expenses which relate to the time period as approved in the Form 3CM. We accordingly hold that the assessee is very much entitled for claiming the above capital and revenue expenses incurred on in house research and development amounting to Rs.237,77,05,310/-. The Assessing Officer had rightly held it entitled for the above weighted deduction after verifying all necessary particulars during the course of scrutiny.

    8. We make it clear before parting that the ld. Departmental Representative has referred to various case laws i.e. Addl.CIT vs. Mukur

    8

    Corporation [1978] 111 ITR 312 (Guj.), Tejas Networks Ltd. vs. DCIT [2015] 60 taxmann.com 309 (Karnataka), Electronics Corpn. Of India Ltd. vs. ACIT [2012] 28 taxmann.com 280 (Hud.), DCIT vs. Mastek Ltd. [2012] 25 taxmann.com 133 (Guj.) & EIMCO K.C.P. Ltd. vs. CIT [2000] 242 ITR 659 (SC). We however find that the first one of the above decision defines the scope of CIT's jurisdiction vested u/s.263 of the Act. We refer facts of the instant case when once again wherein the ld. PCIT has observed in preceding paragraphs that the said jurisdiction is triggered if any Assessing Officer does not frame an assessment as per law. We have already held that the assessee's weighted deduction claim raised u/s.35(2AB) of the Act is very much allowable. The first decision cited at Revenue's behest is accordingly distinguished. Next juridical precedent is (2000) 242ITR 659(SC) EIMCO KCP Ltd. vs. CIT wherein ambit of Section 263 jurisdiction in case pendency of appeal preferred before the CIT(A) is discussed. The same is once again not relevant. Third case law is that of Mukul Corporation (supra) once again throwing light on nature and scope of Section 263 jurisdiction. We have no reason to disagree with the same except the fact that the assessee has already made out its case for claiming the impugned weighted deduction. Ld. Departmental Representative then invites our attention to MASTEK case laws involving Section 35 deduction claim vis-à-vis Section 43(4) of the Act defining scientific research which is not germane to the issue involved before us. Ld. Departmental Representative at last cites hon'ble Karnatka high court's decision in (2015) 60 taxmann.com 309 Tejas Networks Ltd. vs. DCIT involving Section 35 deduction claim in light of Section 43 once again. We have already observed that hon'ble jurisdictional high Court has settled the very proposition in CLARIS case (supra). We therefore find no reason for not following on hon'ble jurisdictional high court's decision binding upon us. Ld. Departmental Representative then invites our attention of this tribunal's Hyderabad bench's decision in Electronics Corporation of India

    9

    Ltd. not taking into consideration the above hon'ble jurisdictional high court's decision which is accordingly distinguished. We thus decline Revenue's arguments.

    9. This assessee's appeal is allowed. [Pronounced in the open Court on this the 22ndday of December, 2016.] Sd/- Sd/-

    (N. K. Billaiya) True Copy (S. S. GODARA)

    ACCOUNTANT MEMBER JUDICIAL MEMBER

    Ahmedabad: Dated 22 /12/2016

    S.K.SINHA

    आदेश क  त ल प अे षत / Copy of Order Forwarded to:-

    1. राज व / Revenue

    2. आवदे क / Assessee

    3. संबंधत आयकर आयु!त / Concerned CIT

    4. आयकर आयु!त- अपील / CIT (A)

    5. )वभागीय ,-त-नध, आयकर अपीलय अधकरण, अहमदाबाद / DR, ITAT, Ahmedabad

    6. गाड 3 फाइल / Guard file. By order/आदेश से,

    उप/सहायक पंजीकार

    आयकर अपीलय अधकरण, अहमदाबाद ।

    10

    Use AI to get other relevant cases.

    Comments

    Sun Pharmaceutical Industries Ltd. v. Cit
    (Dec 22, 2016)